American Oriental Bioengineering, Inc.
AOBI · OTC
9/30/2013 | 6/30/2013 | 3/31/2013 | 12/31/2012 | |
|---|---|---|---|---|
| Market Cap | $4,111 | $4,379 | $4,122 | $14,074 |
| - Cash | $3,231 | $7,005 | $6,416 | $7,097 |
| + Debt | $92,769 | $64,685 | $62,676 | $67,643 |
| Enterprise Value | $93,649 | $62,060 | $60,382 | $74,620 |
| Revenue | $17,936 | $20,224 | $21,007 | $62,414 |
| % Growth | -11.3% | -3.7% | -66.3% | – |
| Gross Profit | $3,108 | $4,986 | $4,501 | $27,027 |
| % Margin | 17.3% | 24.7% | 21.4% | 43.3% |
| EBITDA | -$16,008 | -$7,234 | -$16,965 | -$31,187 |
| % Margin | -89.3% | -35.8% | -80.8% | -50% |
| Net Income | -$21,177 | -$12,841 | -$21,115 | -$35,886 |
| % Margin | -118.1% | -63.5% | -100.5% | -57.5% |
| EPS Diluted | -290.36 | -176.28 | -288.69 | -485.66 |
| % Growth | -64.7% | 38.9% | 40.6% | – |
| Operating Cash Flow | -$17,053 | -$3,021 | -$1,853 | -$9,314 |
| Capital Expenditures | -$13,744 | -$1,018 | -$358 | -$13,292 |
| Free Cash Flow | -$30,797 | -$4,039 | -$2,211 | -$22,605 |